143 related articles for article (PubMed ID: 38379276)
61. Analysis of the epidermal growth factor receptor/phosphoinositide-dependent protein kinase-1 axis in tumor of the external auditory canal in response to epidermal growth factor stimulation.
Akiyama N; Yamamoto-Fukuda T; Yoshikawa M; Kojima H
Laryngoscope Investig Otolaryngol; 2022 Jun; 7(3):730-739. PubMed ID: 35734041
[TBL] [Abstract][Full Text] [Related]
62. Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification.
Alvarez G; Perry A; Tan BR; Wang HL
Mod Pathol; 2006 Jul; 19(7):942-9. PubMed ID: 16648870
[TBL] [Abstract][Full Text] [Related]
63. [Diagnosis and treatment of rare malignant tumors in external auditory canal].
Wang F; Wu N; Hou Z; Liu J; Shen W; Han W; Yang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 29(16):1438-42. PubMed ID: 26665451
[TBL] [Abstract][Full Text] [Related]
64. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
Prabhu R; Hinerman RW; Indelicato DJ; Morris CG; Werning JW; Vaysberg M; Amdur RJ; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2009 Aug; 32(4):401-4. PubMed ID: 19398900
[TBL] [Abstract][Full Text] [Related]
65. Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials.
Lassen P; Overgaard J; Eriksen JG
Radiother Oncol; 2013 Sep; 108(3):489-94. PubMed ID: 24060179
[TBL] [Abstract][Full Text] [Related]
66. Prognostic factors for squamous cell carcinoma of the temporal bone: extensive bone involvement or extensive soft tissue involvement?
Ito M; Hatano M; Yoshizaki T
Acta Otolaryngol; 2009 Nov; 129(11):1313-9. PubMed ID: 19863330
[TBL] [Abstract][Full Text] [Related]
67. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.
Lérias S; Esteves S; Silva F; Cunha M; Cochicho D; Martins L; Félix A
Mod Pathol; 2020 May; 33(5):893-904. PubMed ID: 31844270
[TBL] [Abstract][Full Text] [Related]
68. Effect of Piecemeal vs En Bloc Approaches to the Lateral Temporal Bone on Survival Outcomes.
Muelleman T; Chowdhury NI; Killeen D; Sykes K; Kutz JW; Isaacson B; Staecker H; Lin J
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):716-720. PubMed ID: 29460680
[TBL] [Abstract][Full Text] [Related]
69. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
70. Immunohistochemical assessment of p16, COX-2 and EGFR in HPV-positive cervical squamous intraepithelial lesions.
Balan R; Simion N; Giuşcă SE; Grigoraş A; Gheucă-Solovăstru L; Gheorghiţă V; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2011; 52(4):1187-94. PubMed ID: 22203921
[TBL] [Abstract][Full Text] [Related]
71. Squamous Cell Carcinoma of the External Auditory Canal and Temporal Bone: An Update.
Allanson BM; Low TH; Clark JR; Gupta R
Head Neck Pathol; 2018 Sep; 12(3):407-418. PubMed ID: 30069837
[TBL] [Abstract][Full Text] [Related]
72. Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma.
Fujii M; Yamashita T; Ishiguro R; Tashiro M; Kameyama K
Auris Nasus Larynx; 2002 Apr; 29(2):175-81. PubMed ID: 11893453
[TBL] [Abstract][Full Text] [Related]
73. External Auditory Canal Carcinoma With An Unusually Extensive Invasion.
Shahbaz H; Tahir M; Junaid T; Shakir N; Ahmed Z
J Pak Med Assoc; 2023 Jul; 73(7):1560-1562. PubMed ID: 37469088
[TBL] [Abstract][Full Text] [Related]
74. Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).
Hashmi AA; Bukhari U; Aslam M; Joiya RS; Kumar R; Malik UA; Zia S; Khan AR; Saleem M; Irfan M
Cureus; 2023 Jul; 15(7):e41941. PubMed ID: 37588336
[TBL] [Abstract][Full Text] [Related]
75. Epidermal growth factor receptor expression in squamous cell carcinoma of the hypopharynx.
Frank JL; Garb JL; Banson BB; Peterman J; Neifeld JP; Kay S; Kornstein MJ; Sismanis A; Ware JL
Surg Oncol; 1993; 2(3):161-7. PubMed ID: 8252205
[TBL] [Abstract][Full Text] [Related]
76. p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis.
Su Y; Cui J; Xu D; Wang M; Xu T; Tian H; Han F
Crit Rev Oncol Hematol; 2018 Apr; 124():11-20. PubMed ID: 29548481
[TBL] [Abstract][Full Text] [Related]
77. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
78. [Carcinoma of the external auditory canal and middle ear: therapeutic strategy and follow up].
Kollert M; Draf W; Minovi A; Hofmann E; Bockmühl U
Laryngorhinootologie; 2004 Dec; 83(12):818-23. PubMed ID: 15611900
[TBL] [Abstract][Full Text] [Related]
79. Basal cell carcinoma of the external auditory canal.
Vandeweyer E; Thill MP; Deraemaecker R
Acta Chir Belg; 2002 Apr; 102(2):137-40. PubMed ID: 12051089
[TBL] [Abstract][Full Text] [Related]
80. p16 expression in carcinoma of unknown primary: diagnostic indicator and prognostic marker.
Vent J; Haidle B; Wedemeyer I; Huebbers C; Siefer O; Semrau R; Preuss SF; Klussmann J
Head Neck; 2013 Nov; 35(11):1521-6. PubMed ID: 23345170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
